China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com

Share Article

LifeScienceIndustryResearch.com adds “Research Report on China Avian Influenza Vaccine Industry, 2014-2018” as the latest report to its store.

China Avian Influenza Vaccine Industry

China Avian Influenza Vaccine Industry

Avian influenza vaccines have been used for more than 10 years in China.

Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.

Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago without compulsory requirements. The Chinese avian influenza vaccine industry was in the initial stage in 2001-2005 with upcoming problems. To resolve these problems, the Ministry of Agriculture of China set up an entry barrier for the avian influenza vaccine production and imposes strict supervision. The Ministry of Agriculture of China established strict regulations on the production and sale of avian influenza vaccines. For instance, avian influenza vaccines must be produced in workshops that are in compliance with GMP and inspected every year. Place a direct purchase order at http://www.lifescienceindustryresearch.com/purchase?rname=22859 .

In China, the subsidy provided by the government over killing the infected poultry is CNY 10 per bird. In case of serious epidemic diseases, the subsidy amount will be higher.

In 2013, the live stock volume of laying hens in China was about 1.4 billion, while that of broilers was approximately 10 billion. The output volume of eggs in China was 28.76 million tons in 2013, up by 0.5% YOY. According to National Compulsory Immunization Plan of Animal Epidemic Diseases 2013 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly pathogenic avian influenza. The government is responsible for the expenses. In 2013, the market size of avian influenza vaccines exceeded CNY 1 billion in China. The complete report is available at http://www.lifescienceindustryresearch.com/research-report-on-china-avian-influenza-vaccine-industry-2014-2018.html .

With the increasing living standards of Chinese people, the demand for eggs and poultry meat is growing accordingly, which promotes the development of the poultry industry. In China and other neighboring countries, avian influenza, especially highly pathogenic avian influenza, has not been effectively controlled yet. For example, H5N1 highly pathogenic avian influenza broke out in North Korea in May 2013. Besides H5N1, H5 and H7 and other subtype highly pathogenic avian influenza are also highly possible to break out.

Therefore, it is predicted that the market size of avian influenza vaccines will keeping increasing and many animal healthcare enterprises attach attention to this market.

Through this report, the readers can acquire the following information:

  • Incidence Status of Avian Influenza
  • Status of Poultry Breeding in China
  • Policy Environment and Government Procurement for Avian Influenza Vaccines in China
  • Supply and demand Status of Avian Influenza Vaccines in China
  • Major Manufacturers of Avian Influenza Vaccines and the Operation Status in China
  • Prospect of China Avian Influenza Vaccine Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Poultry Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about the Avian Influenza Vaccine Industry

Browse more reports on Pharmaceuticals Market at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:
Life Science Industry Research is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, biotechnology, diagnostics, healthcare as well as medical devices and pharmaceuticals. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details to sales(at)lifescienceindustryresearch(dot)com. Call and we would be happy to help you find the business intelligence that you need.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
ReportsnReports
Like >
Follow us on
Visit website